Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 3Genitourinary 3Gastrointestinal 3Thoracic 2Sarcoma 2Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Sarcoma 317Glioblastoma 176Gliosarcoma 166Astrocytoma 125Brain Neoplasms 117Osteosarcoma 101Glioma 97Central Nervous System Neoplasms 96Oligodendroglioma 92Neuroblastoma 88Neoplasms 87Melanoma 87Breast Neoplasms 81Ovarian Neoplasms 70Lymphoma 67Dendritic Cell Sarcoma, Interdigitating 64Sarcoma, Ewing 63Rhabdomyosarcoma 63Recurrence 63Carcinoma, Non-Small-Cell Lung 63Precursor Cell Lymphoblastic Leukemia-Lymphoma 59Burkitt Lymphoma 59Lymphoma, Non-Hodgkin 55Medulloblastoma 53Colorectal Neoplasms 53Wilms Tumor 52Pancreatic Neoplasms 51Neoplasm Metastasis 49Lymphoma, Large B-Cell, Diffuse 47Carcinoma, Hepatocellular 44

Interventions

Bacterial Load 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Hypoxia × Sarcoma × Clear all
NCT01924689 2019-09-09

Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

BioMed Valley Discoveries, Inc

Phase 1 Completed
24 enrolled 18 charts
Sarcoma

Hypoxia, Chordoma, Necrosis, Neoplasm Metastasis, Neoplasms, Sarcoma

NCT00358397 2016-10-14

One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Terminated
2 enrolled
GastrointestinalGenitourinarySarcomaThoracic

Hypoxia, Urinary Bladder Neoplasms, Colonic Neoplasms, Lung Neoplasms, Necrosis, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡